上(shang)海璃(li)道醫藥(yao)(yao)科技(ji)有(you)限公司(si)成立(li)于2016年(nian)2月,是一(yi)(yi)家(jia)瞄準前沿科技(ji)的創新藥(yao)(yao)物(wu)(wu)研(yan)(yan)(yan)(yan)發(fa)(fa)公司(si),致力于靶向離子(zi)(zi)通(tong)道進(jin)行相關疾病的藥(yao)(yao)物(wu)(wu)研(yan)(yan)(yan)(yan)發(fa)(fa),如疼痛、癲癇(xian)、抑郁和(he)神經退行性(xing)疾病等。公司(si)堅持走自主創新道路,同(tong)時擁(yong)有(you)一(yi)(yi)支(zhi)在離子(zi)(zi)通(tong)道藥(yao)(yao)物(wu)(wu)研(yan)(yan)(yan)(yan)發(fa)(fa)領域經驗豐富且具有(you)國際視野的研(yan)(yan)(yan)(yan)發(fa)(fa)團隊。自成立(li)以來,公司(si)建立(li)了完(wan)備的藥(yao)(yao)物(wu)(wu)化學(xue)和(he)離子(zi)(zi)通(tong)道藥(yao)(yao)物(wu)(wu)研(yan)(yan)(yan)(yan)發(fa)(fa)平臺和(he)團隊,可獨立(li)開展針對(dui)離子(zi)(zi)通(tong)道靶點的藥(yao)(yao)物(wu)(wu)合成、活性(xing)篩選和(he)早期安(an)全藥(yao)(yao)理學(xue)研(yan)(yan)(yan)(yan)究。公司(si)與國內(nei)外高等院(yuan)校(xiao)、科研(yan)(yan)(yan)(yan)院(yuan)所和(he)上(shang)市醫藥(yao)(yao)集團建立(li)了緊(jin)密的合作關系,已申(shen)請PCT專利5項、中(zhong)國發(fa)(fa)明(ming)專利9項,獲得授權6項。